Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment With Omalizumab in Food Allergic Children (TOFAC)

NCT04037176 is registered in ClinicalTrials.gov with Carsten Bindslev-Jensen as lead sponsor.

NCT NCT04037176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04037176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment With Omalizumab in Food Allergic Children (TOFAC)
Lead sponsor
Carsten Bindslev-Jensen
Phase
Phase 4
Overall status
Completed
Start date
November 1, 2019
Completion date
March 15, 2022
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

food allergy